Drugmakers reportedly push Trump administration to protect China deals
The Wall Street Journal reports that a surge in U.S.-China transactions is drawing scrutiny in Washington, where some lawmakers are pushing to slow the pace of investment.
TLDR
Pharmaceutical companies are pushing the Trump administration to protect China deals, The Wall Street Journal reports. The effort comes as a surge in U.S.-China transactions draws scrutiny in Washington, with some lawmakers pushing to slow the pace of investment.
Combined views
108.2K
2 Sources, first seen 9d ago
78 likes17 comments13 saves26 reposts